106 related articles for article (PubMed ID: 29953857)
1. The peptide mimicking small extracellular loop domain of CD82 inhibits tumor cell migration, adhesion and induces apoptosis by inhibiting integrin mediated signaling.
Luan M; He X; Huang X; Zhang Q; Ma K
Biochem Biophys Res Commun; 2018 Sep; 503(4):2206-2211. PubMed ID: 29953857
[TBL] [Abstract][Full Text] [Related]
2. The peptide mimicking small extracellular ring domain of CD82 inhibits tumor cell migration in vitro and metastasis in vivo.
He X; Ma X; Wang C; Luan M; Li Y; Huang X; Ma K
J Cancer Res Clin Oncol; 2021 Jul; 147(7):1927-1934. PubMed ID: 33811273
[TBL] [Abstract][Full Text] [Related]
3. The metastasis suppressor CD82/KAI1 inhibits fibronectin adhesion-induced epithelial-to-mesenchymal transition in prostate cancer cells by repressing the associated integrin signaling.
Lee J; Byun HJ; Lee MS; Jin YJ; Jeoung D; Kim YM; Lee H
Oncotarget; 2017 Jan; 8(1):1641-1654. PubMed ID: 27926483
[TBL] [Abstract][Full Text] [Related]
4. Metastasis suppressor KAI1/CD82 attenuates the matrix adhesion of human prostate cancer cells by suppressing fibronectin expression and β1 integrin activation.
Lee HA; Park I; Byun HJ; Jeoung D; Kim YM; Lee H
Cell Physiol Biochem; 2011; 27(5):575-86. PubMed ID: 21691075
[TBL] [Abstract][Full Text] [Related]
5. Small extracellular ring domain is necessary for CD82/KAI1'anti-metastasis function.
Ma X; He X; Wang C; Huang X; Li Y; Ma K
Biochem Biophys Res Commun; 2021 Jun; 557():110-116. PubMed ID: 33862453
[TBL] [Abstract][Full Text] [Related]
6. The peptide mimicking small extracellular ring domain of CD82 inhibits epithelial-mesenchymal transition by downregulating Wnt pathway and upregulating hippo pathway.
He X; Huang X; Wang C; Luan M; Li Y; Ma X; Ma K
Biochem Biophys Res Commun; 2020 Dec; 533(3):338-345. PubMed ID: 32958256
[TBL] [Abstract][Full Text] [Related]
7. Tetraspanin KAI1/CD82 suppresses invasion by inhibiting integrin-dependent crosstalk with c-Met receptor and Src kinases.
Sridhar SC; Miranti CK
Oncogene; 2006 Apr; 25(16):2367-78. PubMed ID: 16331263
[TBL] [Abstract][Full Text] [Related]
8. MGAT3-mediated glycosylation of tetraspanin CD82 at asparagine 157 suppresses ovarian cancer metastasis by inhibiting the integrin signaling pathway.
Li J; Xu J; Li L; Ianni A; Kumari P; Liu S; Sun P; Braun T; Tan X; Xiang R; Yue S
Theranostics; 2020; 10(14):6467-6482. PubMed ID: 32483464
[No Abstract] [Full Text] [Related]
9. Effect of KAI1/CD82 on the beta1 integrin maturation in highly migratory carcinoma cells.
Jee BK; Lee JY; Lim Y; Lee KH; Jo YH
Biochem Biophys Res Commun; 2007 Aug; 359(3):703-8. PubMed ID: 17560548
[TBL] [Abstract][Full Text] [Related]
10. Distinctive signaling pathways through CD82 and beta1 integrins in human T cells.
Iwata S; Kobayashi H; Miyake-Nishijima R; Sasaki T; Souta-Kuribara A; Nori M; Hosono O; Kawasaki H; Tanaka H; Morimoto C
Eur J Immunol; 2002 May; 32(5):1328-37. PubMed ID: 11981820
[TBL] [Abstract][Full Text] [Related]
11. Transmembrane interactions are needed for KAI1/CD82-mediated suppression of cancer invasion and metastasis.
Bari R; Zhang YH; Zhang F; Wang NX; Stipp CS; Zheng JJ; Zhang XA
Am J Pathol; 2009 Feb; 174(2):647-60. PubMed ID: 19116362
[TBL] [Abstract][Full Text] [Related]
12. Diallyl trisulfide inhibits cell migration and invasion of human melanoma a375 cells via inhibiting integrin/facal adhesion kinase pathway.
Wang HC; Chu YL; Hsieh SC; Sheen LY
Environ Toxicol; 2017 Nov; 32(11):2352-2359. PubMed ID: 28741790
[TBL] [Abstract][Full Text] [Related]
13. Glycosylation effect on membrane domain (GEM) involved in cell adhesion and motility: a preliminary note on functional alpha3, alpha5-CD82 glycosylation complex in ldlD 14 cells.
Ono M; Handa K; Withers DA; Hakomori S
Biochem Biophys Res Commun; 2000 Dec; 279(3):744-50. PubMed ID: 11162423
[TBL] [Abstract][Full Text] [Related]
14. Dissecting the diverse functions of the metastasis suppressor CD82/KAI1.
Tsai YC; Weissman AM
FEBS Lett; 2011 Oct; 585(20):3166-73. PubMed ID: 21875585
[TBL] [Abstract][Full Text] [Related]
15. KAI1/CD82, a tumor metastasis suppressor.
Liu WM; Zhang XA
Cancer Lett; 2006 Aug; 240(2):183-94. PubMed ID: 16260083
[TBL] [Abstract][Full Text] [Related]
16. Celastrol acts as a potent antimetastatic agent targeting beta1 integrin and inhibiting cell-extracellular matrix adhesion, in part via the p38 mitogen-activated protein kinase pathway.
Zhu H; Liu XW; Cai TY; Cao J; Tu CX; Lu W; He QJ; Yang B
J Pharmacol Exp Ther; 2010 Aug; 334(2):489-99. PubMed ID: 20472666
[TBL] [Abstract][Full Text] [Related]
17. The membrane scaffold CD82 regulates cell adhesion by altering α4 integrin stability and molecular density.
Termini CM; Cotter ML; Marjon KD; Buranda T; Lidke KA; Gillette JM
Mol Biol Cell; 2014 May; 25(10):1560-73. PubMed ID: 24623721
[TBL] [Abstract][Full Text] [Related]
18. CD82 suppresses CD44 alternative splicing-dependent melanoma metastasis by mediating U2AF2 ubiquitination and degradation.
Zhang P; Feng S; Liu G; Wang H; Fu A; Zhu H; Ren Q; Wang B; Xu X; Bai H; Dong C
Oncogene; 2016 Sep; 35(38):5056-5069. PubMed ID: 27041584
[TBL] [Abstract][Full Text] [Related]
19. Cisplatin at sub-toxic levels mediates integrin switch in lung cancer cells.
Maiuthed A; Chanvorachote P
Anticancer Res; 2014 Dec; 34(12):7111-7. PubMed ID: 25503138
[TBL] [Abstract][Full Text] [Related]
20. Tetraspanin CD82 drives acute myeloid leukemia chemoresistance by modulating protein kinase C alpha and β1 integrin activation.
Floren M; Restrepo Cruz S; Termini CM; Marjon KD; Lidke KA; Gillette JM
Oncogene; 2020 May; 39(19):3910-3925. PubMed ID: 32203165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
